1
Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer
Condition(s):Non Castrate Metastatic Prostate CancerLast Updated:November 17, 2017Terminated
Bicalutamide: 226 Clinical Trials, Page 1 of 23
Hide Studies Not Open or Pending
2
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
Condition(s):Non-Muscle Invasive Bladder CancerLast Updated:July 15, 2022Recruiting
3
Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer
Condition(s):Metastatic Triple Negative Breast CancerLast Updated:January 28, 2021Terminated
4
FDHT PET and Bicalutamide in Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:November 27, 2019Completed
5
Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients
Condition(s):Breast CancerLast Updated:January 23, 2018Terminated
6
AR-inhibitor Bicalutamide in Treating Patients With TNBC
Condition(s):Breast NeoplasmsLast Updated:February 3, 2015Unknown status
7
A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance
Condition(s):Detectable Prostate NodulesLast Updated:March 22, 2017Withdrawn
8
Camostat With Bicalutamide for COVID-19
Condition(s):Covid19; SARS-CoV Infection; Coronavirus InfectionLast Updated:September 22, 2021Terminated
9
Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection
Condition(s):COVID-19Last Updated:July 1, 2021Withdrawn
10
Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:December 22, 2017Unknown status